| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.045 | 0.3 |